A step-by-step framework for evaluating foot and ankle practices, from Medicare payer mix to physician transition risk, before you close.
Find Podiatry Practice Acquisition TargetsAcquiring a podiatry practice requires healthcare-specific due diligence beyond standard business financials. Buyers must assess payer mix sustainability, physician-level revenue concentration, billing compliance exposure, and state corporate practice of medicine laws. This guide covers every critical checkpoint for $1M–$5M podiatry acquisitions.
Validate the true earnings power of the practice by normalizing owner compensation, auditing collections, and stress-testing payer mix concentration risk.
Analyze collections by payer — Medicare, Medicaid, commercial — over 3 years. Flag practices exceeding 60% Medicare concentration, which limits reimbursement upside and increases CMS policy risk.
Recast financials to separate true EBITDA from owner salary, personal expenses, and above-market perks. Podiatry practices commonly show 15–30% EBITDA margins post-normalization.
Review AR aging buckets and claim denial rates by payer. High 90-day-plus balances or recurring coding denials signal revenue cycle dysfunction requiring post-close remediation investment.
Assess the practice's regulatory standing, billing integrity, and operational independence from the selling physician to identify compliance exposure and transition risk.
Audit CPT coding patterns for diabetic foot care, orthotics, and wound care against Medicare LCD policies. Identify upcoding patterns, overpayment demands, or open RAC audit exposure.
Confirm all referral arrangements, physician compensation structures, and ancillary service income comply with Stark Law and anti-kickback statutes. Engage healthcare counsel before closing.
Confirm all provider licenses and DEA registrations are current. Verify state-specific corporate practice of medicine laws to ensure the buyer's proposed ownership structure is legally permissible.
Evaluate the risk that revenue walks out the door with the selling physician and confirm the practice has enterprise-level goodwill transferable to new ownership.
Quantify what percentage of collections are directly tied to the selling podiatrist. Practices where one physician generates over 80% of revenue require structured earnouts or extended transition periods.
Review employment agreements, compensation structures, and non-competes for all associate podiatrists and PAs. Confirm they are willing to remain post-acquisition and review productivity metrics.
Analyze appointment volume trends, recall rates, and referral concentration from PCPs, orthopedic surgeons, and endocrinologists. Confirm referral relationships are practice-level, not physician-personal.
Podiatry practices typically trade at 3x–5.5x adjusted EBITDA. Practices with associate coverage, diversified payer mix, and strong recurring diabetic care volume command the higher end of this range.
Yes. Podiatry practices are SBA-eligible. Most deals are structured with 10–15% buyer equity, an SBA 7(a) loan covering 75–80%, and a seller note or earnout covering the remaining balance.
Negotiate a 12–24 month employment agreement with the seller, tie earnout payments to patient retention targets, and ensure associate providers are credentialed and visible to patients before the transition.
Medicare billing exposure is the top risk — particularly for orthotics, routine foot care, and wound care coding. Commission a pre-close billing audit to quantify any overpayment liability before finalizing purchase price.
More Podiatry Practice Guides
DealFlow OS surfaces targets with seller signals and motivation scores — so you know before you start diligence. Free to join.
Start finding deals — freeNo credit card required
For Buyers
For Sellers